Why WAM Research Limited (ASX:WAX) is getting more attractive as a dividend share

WAM Research Limited (ASX:WAX) is becoming increasingly an attractive dividend share.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I think that WAM Research Limited (ASX: WAX) is one of the most attractive dividend shares on the ASX.

It's a listed investment company (LIC) that is run by the high-performing Wilson Asset Management (WAM) team.

It focuses on small and medium sized businesses that the team view as growth opportunities where they can see a catalyst that will change the valuation.

This strategy has been very effective because over the past five years its portfolio has returned an average of 13.9% per annum before fees and expenses, outperforming the S&P/ASX All Ordinaries Accumulation Index by 7.7% per annum, not including franking credits.

WAM Research has used this excellent performance to pay a growing fully franked dividend, it has increased its dividend each year since the GFC.

However, October was a rough month with the WAM Research portfolio falling by 9%. WAM Research has increased its cash position to 38.2% of the portfolio, up from 21.1% in September, to weather any future volatility.

The reason why I think WAM Research is an even more attractive dividend option is because the LIC's Board aims to increase the dividend steadily each year. This means that FY19's dividend should be higher than FY18's barring a catastrophe. That means that a falling share price should translate to a higher starting dividend yield.

WAM Research's current grossed-up dividend yield is 9.3%, which is a very nice starting yield.

Foolish takeaway

However, the one thing holding me back from investing at the current price is that the current share price of $1.46 means it's trading at a premium of around 25% to the pre-tax net tangible assets (NTA) per share at the end of October 2018.

I don't think I'll be buying shares of WAM Research until the grossed-up yield is 10% or higher or the premium reduces significantly. But I do prefer it to WAM Capital Limited (ASX: WAM).

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »